Payment overview · 2025
General Payments
$70.19
3 reported records · 3 companies
Healthcare provider profile · identity verified
Brian Eklund, MD
Allopathic & Osteopathic Physicians|Internal Medicine · ELIZABETHTOWN, KY · NPI 1386635670
Verified facts
What the public records show
CMS Open Payments records show Brian Eklund, MD received $70.19 in general payments during 2025 across 3 reported records.
Averitas Pharma Inc. accounted for 49.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Averitas Pharma Inc. | Unresolved — no canonical attribution shown | $34.43 | 49.0% | 1 | 2025 |
| Daiichi Sankyo Inc. | Unresolved — no canonical attribution shown | $21.50 | 30.6% | 1 | 2025 |
| Almatica Pharma LLC | Unresolved — no canonical attribution shown | $14.26 | 20.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $70.19 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| QUTENZA Normalized: qutenza |
Drug | Averitas Pharma Inc. | $34.43 | 1 | 2025 |
Source payment records
|
|||||
| INJECTAFER Normalized: injectafer |
Drug | Daiichi Sankyo Inc. | $21.50 | 1 | 2025 |
Source payment records
|
|||||
| LOREEV XR Normalized: loreev xr |
Drug | Almatica Pharma LLC | $14.26 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 847 | 238 |
| Levothyroxine Sodium | Levothyroxine Sodium | 693 | 182 |
| Amlodipine Besylate | Amlodipine Besylate | 502 | 151 |
| Gabapentin | Gabapentin | 498 | 129 |
| Metoprolol Succinate | Metoprolol Succinate | 447 | 124 |
| Lisinopril | Lisinopril | 432 | 120 |
| Montelukast Sodium | Montelukast Sodium | 328 | 89 |
| Omeprazole | Omeprazole | 281 | 85 |
| Losartan Potassium | Losartan Potassium | 264 | 79 |
| Pravastatin Sodium | Pravastatin Sodium | 247 | 63 |
| Furosemide | Furosemide | 244 | 70 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 228 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 223 | 78 |
| Simvastatin | Simvastatin | 217 | 59 |
| Potassium Chloride | Potassium Chloride | 209 | 68 |
| Eliquis | Apixaban | 202 | 42 |
| Prednisone | Prednisone | 193 | 140 |
| Sertraline Hcl | Sertraline Hcl | 191 | 58 |
| Metformin Hcl Er | Metformin Hcl | 181 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 180 | 49 |
| Ezetimibe | Ezetimibe | 178 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 175 | 54 |
| Glimepiride | Glimepiride | 167 | 47 |
| Tramadol Hcl | Tramadol Hcl | 155 | 39 |
| Allopurinol | Allopurinol | 152 | 44 |
| Famotidine | Famotidine | 148 | 48 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 146 | 55 |
| Escitalopram Oxalate | Escitalopram Oxalate | 145 | 37 |
| Ozempic | Semaglutide | 145 | 32 |
| Carvedilol | Carvedilol | 137 | 40 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 132 | 38 |
| Trazodone Hcl | Trazodone Hcl | 127 | 37 |
| Synthroid | Levothyroxine Sodium | 125 | 34 |
| Jardiance | Empagliflozin | 123 | 26 |
| Metformin Hcl | Metformin Hcl | 120 | 37 |
| Meloxicam | Meloxicam | 118 | 40 |
| Clopidogrel | Clopidogrel Bisulfate | 109 | 25 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 107 | 37 |
| Spironolactone | Spironolactone | 107 | 30 |
| Valsartan | Valsartan | 105 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 104 | 37 |
| Januvia | Sitagliptin Phosphate | 90 | 32 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 90 | 20 |
| Celecoxib | Celecoxib | 88 | 26 |
| Alendronate Sodium | Alendronate Sodium | 87 | 28 |
| Lorazepam | Lorazepam | 87 | 22 |
| Ibandronate Sodium | Ibandronate Sodium | 85 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 85 | 23 |
| Pregabalin | Pregabalin | 81 | 19 |
| Bupropion Xl | Bupropion Hcl | 80 | 23 |
| Alprazolam | Alprazolam | 79 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 74 | 33 |
| Atenolol | Atenolol | 73 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 71 | 18 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 69 | 19 |
| Memantine Hcl | Memantine Hcl | 68 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 65 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 62 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 62 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 62 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 61 | 14 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 61 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 60 | 17 |
| Warfarin Sodium | Warfarin Sodium | 60 | 12 |
| Candesartan Cilexetil | Candesartan Cilexetil | 59 | 17 |
| Doxazosin Mesylate | Doxazosin Mesylate | 58 | 17 |
| Cephalexin | Cephalexin | 57 | 48 |
| Temazepam | Temazepam | 57 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 56 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 54 | 18 |
| Donepezil Hcl | Donepezil Hcl | 53 | 17 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 52 | 12 |
| Aripiprazole | Aripiprazole | 52 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 51 | 11 |
| Clonazepam | Clonazepam | 50 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 50 | 13 |
| Finasteride | Finasteride | 49 | 16 |
| Dicyclomine Hcl | Dicyclomine Hcl | 46 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 46 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 44 | suppressed |
| Mirtazapine | Mirtazapine | 44 | 14 |
| Trulicity | Dulaglutide | 44 | 11 |
| Irbesartan | Irbesartan | 43 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 40 | 15 |
| Mounjaro | Tirzepatide | 40 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 40 | 12 |
| Propranolol Hcl | Propranolol Hcl | 37 | suppressed |
| Cefdinir | Cefdinir | 36 | 30 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 36 | 32 |
| Ondansetron Odt | Ondansetron | 32 | 22 |
| Lovastatin | Lovastatin | 31 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 31 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 30 | suppressed |
| Levofloxacin | Levofloxacin | 30 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | suppressed |
| Estradiol | Estradiol | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 28 | 11 |
| Meclizine Hcl | Meclizine Hcl | 28 | 11 |
| Memantine Hcl Er | Memantine Hcl | 28 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 27 | 16 |
| Entresto | Sacubitril/Valsartan | 27 | suppressed |
| Fluconazole | Fluconazole | 27 | 20 |
| Glipizide Er | Glipizide | 27 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 26 | suppressed |
| Nifedipine Er | Nifedipine | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 24 | suppressed |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 19 |
| Nystatin | Nystatin | 23 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 22 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 21 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Scopolamine | Scopolamine | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 17 |
| Azithromycin | Azithromycin | 18 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 12 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 14 |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 16 | suppressed |
| Xarelto | Rivaroxaban | 16 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Nexletol | Bempedoic Acid | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $70.19 · 3 records | Averitas Pharma Inc. | INJECTAFER, LOREEV XR, QUTENZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error